Coronary sinus dilatation. A simple additional echocardiographic indicator of severe rheumatic mitral and tricuspid

Nese Kizilkan1, Vedat Davutoglu, Hulya Erbagci

  • 1Department of Anatomy, Faculty of Medicine, School of Medicine, Gaziantep University, Gaziantep TR 27310, Turkey. kizilkan@gantep.edu.tr

Saudi Medical Journal
|February 23, 2010
PubMed

Insights

Echocardiographic measurement of coronary sinus (CS) diameter can help predict the severity of rheumatic valve disease (RVD). This finding may offer additional insights for managing mitral and tricuspid valve conditions.

Area of Science:

  • Cardiology
  • Echocardiography
  • Valvular Heart Disease

Background:

  • Rheumatic valve disease (RVD) affects heart valves, leading to stenosis or regurgitation.
  • Assessing RVD severity is crucial for patient management and prognosis.
  • Current methods may benefit from additional non-invasive markers.

Purpose of the Study:

  • To investigate the utility of coronary sinus (CS) anatomic diameter as a surrogate marker for RVD severity.
  • To explore the correlation between CS diameter and various hemodynamic and functional parameters in RVD patients.

Main Methods:

  • Cross-sectional observational study involving 88 RVD patients and 104 controls.
  • Echocardiographic assessment of valve function, atrial volumes, pulmonary artery pressure, and left ventricular function.
  • Measurement of coronary sinus diameter as a sonolucency in the posterior atrioventricular groove.

Main Results:

  • Significant positive correlations were observed between CS diameter and mitral mean gradient, mitral/tricuspid regurgitation grade, tricuspid stenosis gradient, pulmonary artery systolic pressure, atrial volumes, and NYHA class.
  • Negative correlations were found between CS diameter and mitral valve area and ejection fraction.
  • Mitral valve area, tricuspid regurgitation grade, and right atrial volume predicted CS dilatation.

Conclusions:

  • Echocardiographic assessment of dilated CS diameter shows potential as an additional tool for predicting RVD severity.
  • Findings suggest CS diameter can provide valuable information for mitral/tricuspid RVD.
  • Further studies are required to confirm these preliminary findings.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...